Ticker League

EBITDA Margin for Bio-Techne (TECH)

As of · Reported

Metric

TTM

21.4%

YoY change

−9.23pp

Trough year (1989)

6.4%

Peak year (2007)

61.3%

EBITDA Margin history chart for Bio-Techne (TECH) from 1989 to 2025

Latest: 17.8%

EBITDA Margin change chart for Bio-Techne (TECH) from 1989 to 2025

Latest: −9.23pp

EBITDA Margin history table for Bio-Techne (TECH) from 1989 to 2025

  • 202517.8%-9.23pp
  • 202427.0%-13.20pp
  • 202340.2%+2.79pp
  • 202237.4%+10.59pp
  • 202126.8%-24.39pp
  • 202051.2%+21.55pp
  • 201929.7%-1.52pp
  • 201831.2%-0.66pp
  • 201731.9%-6.62pp
  • 201638.5%-4.19pp
  • 201542.7%-7.81pp
  • 201450.5%-5.23pp
  • 201355.7%+0.17pp
  • 201255.5%-4.37pp
  • 201159.9%-1.27pp
  • 201061.2%+1.10pp
  • 200960.1%+1.19pp
  • 200858.9%-2.43pp
  • 200761.3%+4.32pp
  • 200657.0%-1.16pp
  • 200558.1%+3.38pp
  • 200454.8%+3.69pp
  • 200351.1%+1.04pp
  • 200250.0%-0.71pp
  • 200150.7%+0.68pp
  • 200050.1%+9.37pp
  • 199940.7%+5.79pp
  • 199834.9%+6.02pp
  • 199728.9%+3.08pp
  • 199625.8%+2.55pp
  • 199523.3%-0.05pp
  • 199423.3%-5.25pp
  • 199328.6%+5.70pp
  • 199222.9%+8.88pp
  • 199114.0%+2.52pp
  • 199011.5%+5.06pp
  • 19896.4%—

EBITDA Margin values are taken from Bio-Techne's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About EBITDA Margin at Bio-Techne (TECH)

According to Bio-Techne's latest reported financial statements, the company's latest reported EBITDA margin is 21.4%. EBITDA margin is EBITDA divided by revenue — earnings before interest, taxes, depreciation, and amortization as a percentage of sales. By stripping out non-cash charges and capital-structure effects, it approximates operating cash profitability and is widely used to compare companies with different asset bases and leverage.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

The 2025 reading of Bio-Techne (TECH) EBITDA margin is 17.78% – contracted 9.2 percentage points year-over-year.

Across the available history, EBITDA margin reached its high of 61.31% in 2007 and its low of 6.40% in 1989.

Bio-Techne EBITDA Margin by Year

Bio-Techne EBITDA Margin 2025: 17.8%

In 2025, Bio-Techne reported EBITDA margin of 17.78%, contracted 9.2 percentage points from 2024.

Bio-Techne EBITDA Margin 2024: 27.0%

Bio-Techne EBITDA margin in 2024 was 27.02%, contracted 13.2 percentage points from 2023.

Bio-Techne EBITDA Margin 2023: 40.2%

2023's EBITDA margin for Bio-Techne came in at 40.21%, expanded 2.8 percentage points from 2022.

Bio-Techne EBITDA Margin 2022: 37.4%

Bio-Techne posted EBITDA margin of 37.42% in 2022, expanded 10.6 percentage points from 2021.

Bio-Techne EBITDA Margin 2021: 26.8%

Bio-Techne EBITDA margin in 2021 was 26.84%.

See more financial history for Bio-Techne (TECH).

Sector peers by EBITDA Margin

Healthcare peers of Bio-Techne (TECH), ranked by their latest EBITDA margin

Frequently asked questions

Bio-Techne (TECH) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation